Bio
Dr. Plante obtained her medical degree from Laval University in 1985 and completed her residency in obstetrics and gynecology at McGill University in 1990. She continued with a 3-year subspecialty in gynecologic oncology at the Memorial Sloan-Kettering Cancer Center in New York in 1993. Since then, she has worked as a gynecologist-oncologist at l’Hôtel-Dieu de Québec.
Dr. Plante is a Professor in the Department of Obstetrics and Gynecology at Laval University. She is head of the oncology-gynecology department and in charge of clinical research at l’Hôtel-Dieu de Québec.
Expertise
- Plante is best known for her expertise in minimally invasive surgery in the treatment of gynecological cancers, including robot-assisted surgery, the sentinel lymph node technique in gynecological cancers and in surgeries aimed at preserving fertility in young women suffering from cervical cancer, including radical trachelectomy.
- Plante is the principal investigator of a large international, prospective and randomized study led by the Canadian Cancer Trials Group (CCTG) and the Gynecologic Cancer InterGroup (GCIG) (CX-5 or SHAPE study). The study aims to randomize patients with early-stage and low-risk cervical cancer to receive either radical hysterectomy (standard) or simple hysterectomy (studied). More than 700 patients will be randomized in this study.
- In addition, Dr. Plante is particularly interested in oncogenetics related to ovarian cancer. She has been involved in the activities of the oncogenetics department, along with the St-Sacrement Hospital team, since its inception, and is responsible for its ovarian component.
Recent Appointments
- Co-chair of CCRN (Cervical Cancer Research Network)
- Chair, International Committee, SGO (Society of Gynecologic Oncology)
- Co-chair, Cervix Working Group, CCTG
- Member, Editorial Board, International Journal of Gynecologic Cancer (IJGC) and Journal of Obstetrics and Gynecology of Canada (JOGC)
11, côte du Palais
Québec, Québec
Canada G1R 2J6
Latest news
Data not available
- Lavallée, MarièveEmployeeL'Hôtel-Dieu de Québec+1 418-525-4444, extension 21629marieve.lavallee@crchudequebec.ulaval.ca
6 Rue McMahon
0680
Québec, QC
Canada G1R 3S1 - Teo-Fortin, Ly-AnnEmployeeL'Hôtel-Dieu de Québecly-ann.teo-fortin@crchudequebec.ulaval.ca
11 Côte du Palais
11611 (Salle 108)
Québec, QC
Canada G1R 0A2
Robotic-assisted surgery for endometrial cancer is safe in morbidly and extremely morbidly obese patients
Journal ArticleGynecol Oncol, 172 , 2023.
Oncologic Outcomes of Surgically Treated Cervical Cancer with No Residual Disease on Hysterectomy Specimen: A 4C (Canadian Cervical Cancer Collaborative) Working Group Study
Journal ArticleCurr Oncol, 30 (2), 2023.
Grade and Estrogen Receptor Expression Identify a Subset of No Specific Molecular Profile Endometrial Carcinomas at a Very Low Risk of Disease-Specific Death
Journal ArticleMod Pathol, 36 (4), 2023.
Molecular subtype stratified outcomes according to adjuvant therapy in endometrial cancer
Journal ArticleGynecol Oncol, 170 , 2023.
Enhancing cervical and breast cancer training in Africa with e-learning
Journal ArticleLancet Glob Health, 11 (1), 2023.
Development, Implementation, and Evaluation of a Distance Learning and Telementoring Program for Cervical Cancer Prevention in Cameroon
Journal ArticleJAMA Netw Open, 5 (11), 2022.
Dataset for the Reporting of Carcinoma of the Cervix: Recommendations From the International Collaboration on Cancer Reporting (ICCR)
Journal ArticleInt J Gynecol Pathol, 41 (Suppl 1), 2022.
Variability in endometrial carcinoma pathology practice: opportunities for improvement with molecular classification
Journal ArticleMod Pathol, 35 (12), 2022.
Estimation risk of lymph nodal invasion in patients with early-stage cervical cancer: Cervical cancer application
Journal ArticleFront Oncol, 12 , 2022.
Are Women with Antecedent Low-Grade Cytology and <CIN2 Findings in Colposcopy Being Overmanaged
Journal ArticleJ Obstet Gynaecol Can, 44 (10), 2022.
Active projects
- Bourse de Fellow pour le développement d'un projet prospectif panprovincial longitudinal sur le traitement carcinomes et sarcomes utérins., from 2022-09-01 to 2024-09-01